Under one bill, states could license patented drugs to generics companies, paying patent holders a royalty.
Tamsen Valoir
Advertisement
Articles by Tamsen Valoir
As scientists' knowledge of biochemical pathways increases, so does the number of patents issued for generic treatment claims. Such claims represent methods of treating disease by modulating a particular protein in the body.
Advertisement
Latest Updated Articles
Legal: State Compulsory LicensesNovember 1st 2005
- Generic Treatment Claims: Do They Hold Water?
April 1st 2003
Advertisement
Advertisement
Trending on PharmExec
1
AI has Redefined Healthcare Communication — and There’s No Opting Out
2
How FDA's Removal of the Two-Trial Requirement Affects Development Programs
3
Novo Nordisk Signs Deal with Hims & Hers
4
FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer
5